PACCOCATH ISR I/II - Deb-bbraun.de
PACCOCATH ISR I/II - Deb-bbraun.de
PACCOCATH ISR I/II - Deb-bbraun.de
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Conclusions<br />
• First in man trial with a paclitaxel-coated balloon<br />
(<strong>PACCOCATH</strong><br />
technology)<br />
• Angiographic and clinical efficacy up to 24 months<br />
• Safety 24 months<br />
• no late thrombosis<br />
• clopidogrel only for one month<br />
• No coating-related adverse events<br />
• Inhibition of restenosis by drug-coated balloons does not<br />
require stent implantation and sustained drug release at<br />
the site of injury.
Change language